FDA News
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 1–12 of 26 articles
Quick answer
NovaPharmaNews FDA News hub for NMPA covers 26 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Fosun Pharma and AriBio Forge Alzheimer's Option Agreement: Deal Intelligence
NMPA China FDA Drug Approval: 2026 Pathways, Timelines & Impact
Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates
Cell and Gene Therapy Approvals in China: Latest Regulatory Updates
A Decade of AI Medical Device Regulation: Key Updates for Pharma
Regulatory Round-Up: Key Drug Approvals on May 18, 2026
Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's
Optical Coherence Tomography Gains Regulatory Traction in Pharma Filings
Datroway Approved: A New Hope for Metastatic TNBC Patients
Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
AbbVie Secures FDA Approval for ImmunoGen's Elahere
Big Pharma's China Oncology Trials: Navigating a Landscape of Reduced Scrutiny
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.